Examination of the effectiveness of early diagnosis and treatment performed by magnetic resonance imaging (MRI) of hepatocellular carcinoma with liver specific contrast agent. - Examination of the effectiveness of early diagnosis and treatment of HCC by EOB-MRI

Gastroenterology of the university of Tokyo hospital0 sites140 target enrollmentJanuary 21, 2013

Overview

Phase: Phase 4
Intervention: Not specified
Conditions: Targeted to chronic liver disease patients undergoing abdominal ultrasonography in regular intervals, diagnosed the early hepatocellular carcinoma or more than 2cm 1.0cm.
Sponsor: Gastroenterology of the university of Tokyo hospital
Enrollment: 140
Status: Completed
Last Updated: 2 years ago

No summary available.

Registry

who.int

Start Date

January 21, 2013

End Date

August 18, 2017

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

Gastroenterology of the university of Tokyo hospital

•Cases correspond to the following exclusion criteria at the time of registration are excluded from the scope. Cases of liver dysfunction or more points 9 Child\-Pugh score Failure in patients with severe hepatic, there are reports that the rate of excretion into feces after administration of gadolinium has dropped to 6%. Patients with renal impairment than eGFR 30mL/min In patients with severe renal impairment, in patients who spoke a foreign nephrogenic systemic fibrosis after gadolinium\-based contrast agent other use has been reported Patients with severe heart disease Patients with severe respiratory disease If the physician has deemed inappropriate sharing research or study investigator.